Current Radiopharmaceuticals : Impact Factor & More
eISSN: 1874-4729pISSN: 1874-4710
Share this on:
Key Metrics
CiteScore 
5.8
H-Index
30
Impact Factor
< 5
SJR
Q3Pharmacology
SNIP
1.03
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Current Radiopharmaceuticals
Current Radiopharmaceuticals Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | BENTHAM SCIENCE PUBL LTD |
| Language | English |
| Frequency | Quarterly |
| General Details | |
| Language | English |
| Frequency | Quarterly |
| Publication Start Year | 2008 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Current Radiopharmaceuticals ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Current Radiopharmaceuticals
Structural MRI reveals brain differences in asthmatic patients with and without atopic dermatitis
- 1 May 2026
- Current Radiopharmaceuticals
EAVS-TF: A bio-inspired spiking neural network for energy-efficient multimodal emotion recognition
- 1 May 2026
- Current Radiopharmaceuticals
Design semi-automated radio-synthesis strategy and synthesis of benzimidazole-based radiotracer 2-(4-(2-(fluoro-18F) ethyl) piperidin-1-yl) benzo imidazo[1,2-a] pyrimidine for Tau as a PET imaging agent
- 1 Mar 2026
- Current Radiopharmaceuticals
M6A RNA methylation: A key regulator in renal cell carcinoma development and tumor radioresistance
- 1 Mar 2026
- Current Radiopharmaceuticals
Dosimetric comparison and clinical evaluation of hybrid three-dimensional conformal radiotherapy and intensity modulated radiotherapy in simultaneous integrated boost radiotherapy for breast cancer
- 1 Mar 2026
- Current Radiopharmaceuticals
Proteomics combined with ultrasound radiomics predicts central lymph node metastasis in papillary thyroid carcinoma
- 1 Mar 2026
- Current Radiopharmaceuticals
Structural MRI reveals brain differences in asthmatic patients with and without atopic dermatitis
- 1 May 2026
- Current Radiopharmaceuticals
EAVS-TF: A bio-inspired spiking neural network for energy-efficient multimodal emotion recognition
- 1 May 2026
- Current Radiopharmaceuticals
Design semi-automated radio-synthesis strategy and synthesis of benzimidazole-based radiotracer 2-(4-(2-(fluoro-18F) ethyl) piperidin-1-yl) benzo imidazo[1,2-a] pyrimidine for Tau as a PET imaging agent
- 1 Mar 2026
- Current Radiopharmaceuticals
M6A RNA methylation: A key regulator in renal cell carcinoma development and tumor radioresistance
- 1 Mar 2026
- Current Radiopharmaceuticals
Dosimetric comparison and clinical evaluation of hybrid three-dimensional conformal radiotherapy and intensity modulated radiotherapy in simultaneous integrated boost radiotherapy for breast cancer
- 1 Mar 2026
- Current Radiopharmaceuticals
Proteomics combined with ultrasound radiomics predicts central lymph node metastasis in papillary thyroid carcinoma
- 1 Mar 2026
- Current Radiopharmaceuticals
FAQs on Current Radiopharmaceuticals
How long has Current Radiopharmaceuticals been actively publishing? 
What is the publishing frequency of Current Radiopharmaceuticals?
How many articles did Current Radiopharmaceuticals publish last year?
What is the eISSN & pISSN for Current Radiopharmaceuticals?
What is Citescore for Current Radiopharmaceuticals?
What is the H Index for Current Radiopharmaceuticals ?
What is SNIP score for Current Radiopharmaceuticals?
What is the SJR for Current Radiopharmaceuticals?
Who is the publisher of Current Radiopharmaceuticals?
